Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
about
Evidence that SOX2 overexpression is oncogenic in the lungThe molecular mechanism governing the oncogenic potential of SOX2 in breast cancerA minimally invasive multiple marker approach allows highly efficient detection of meningioma tumorsAntiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regressionNovel immunogenic antigens increase classification accuracy in meningioma to 93.84%.Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biologyIdentification of lung cancer with high sensitivity and specificity by blood testing.Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinomaEmerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancerImmunity to stemness genes in human cancer.Immunogenicity of autoantigens.Sc65 is a novel endoplasmic reticulum protein that regulates bone mass homeostasisSpontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.Prognostic and diagnostic value of spontaneous tumor-related antibodiesMyasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.Characterizing immunoglobulin repertoire from whole blood by a personal genome sequencerLigation-anchored PCR unveils immune repertoire of TCR-beta from whole blood.Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis.Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls.Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathySOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours.Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancerAssessment of autoantibodies to meningioma in a population-based study.Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer.Novel autoantigens immunogenic in COPD patients.Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.Improving seroreactivity-based detection of glioma.Identifying autoantibody signatures in cancer: a promising challenge.Vaccines targeting cancer stem cells: are they within reach?Embryonic signature in breast cancers; Pluripotency roots of cancer stem cells.Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.SOX2 contributes to melanoma cell invasion.Evaluation of autoantibody signatures in meningioma patients using human proteome arraysSePaCS--a web-based application for classification of seroreactivity profiles.Combining gene expression signatures and autoantibody profiles in human meningioma.Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?
P2860
Q21091126-EF1C2350-5281-48FA-95D8-A4501AFED78BQ24309520-AA728ACA-50A4-4E22-915E-BEE57C000955Q33267383-CD782739-F0A2-43F7-BA39-152BE5254A1BQ33551268-A862316A-81DF-4148-8A77-F266A2F90C4DQ33588789-BB42A42D-4921-4802-A5A8-B10237B2C563Q33597213-044C6A97-DD76-45E7-B6D6-BFA9EA75E4DFQ33705551-9CC30A26-C311-4174-BCB8-8F891D4E2F03Q33747137-887CE313-18D0-459F-8CA2-06DCDA7346D4Q33806378-973F5B10-0EF2-4097-89E6-AE5F22251FFBQ33875325-4254CEF6-45F6-49A3-9680-13D71649E172Q33943241-E689D099-98E2-40EB-A94B-B93838344D6EQ33949907-B20211AD-60A0-432E-B056-F7628A391746Q34033354-6FF4A2FE-F0F9-4665-8F50-9DFD0900C212Q34151620-372A4489-8F0E-48B8-B2FF-DEF0481B0772Q34276070-ECAD71B2-B8AB-43D9-8678-6B442AE98637Q34475795-3D248019-FD4A-4C11-A894-5E066FAC8894Q34618619-1165A47A-A03E-4D62-BDD2-324B7D40BB77Q34995027-34D775A1-D8C8-4A74-BD0E-4D467F930740Q35644152-BBBA4647-1B96-4694-8953-8C5141D47979Q35651467-5CD57778-623E-4721-B8CC-1BF19074F669Q35872473-C039A051-741A-4422-98D3-7E6722114420Q35916610-FC33797A-4BE9-4B36-AD81-F871335C363DQ36229280-AE367EC2-AD63-4495-8BAB-D57775D92DB8Q36365816-B3CEE04A-1105-45D2-820A-3A018452115BQ36642867-6F71FA0C-0AC5-4902-9310-40E161F806F0Q36661782-F2AC3B30-5E1E-4E07-9669-2C650BB130D6Q36709561-1CF0F2A5-A788-44CC-863D-9EC17BA4C772Q37154059-D8F5C092-0F5A-4AF5-ABF2-7E71CFCA56B1Q37349481-F59EDC8D-B971-43AB-968E-263012E70265Q37478666-D26940D8-FC14-434F-A619-B00C6E03AE0AQ37579900-C28B0F69-BEEC-406F-85D4-0CD86C738397Q37939527-4A29C61D-FE20-464A-9267-56D7E4213C00Q38130232-8465E130-3174-4654-90B2-6E3CBE9FDD8DQ39370686-1C3B9267-CDA3-42D0-8E4F-A725FDDD77C0Q39425345-603809FD-71EF-4486-B263-23483277AB9BQ41709447-CC8E9251-4430-417C-BD1F-57BE23DD50CEQ42431923-FB255958-E891-41D9-8A99-C97D5A3AC9A9Q45879684-4FDA6DC2-B96F-430E-B545-0E95D4D85CBEQ47581436-61E91875-0FBC-4EE1-A252-9B258D0D8E5BQ55436808-056DC65F-9931-44D9-88BD-C598799891C8
P2860
Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Complex humoral immune respons ...... ntigens as diagnostic targets.
@ast
Complex humoral immune respons ...... ntigens as diagnostic targets.
@en
type
label
Complex humoral immune respons ...... ntigens as diagnostic targets.
@ast
Complex humoral immune respons ...... ntigens as diagnostic targets.
@en
prefLabel
Complex humoral immune respons ...... ntigens as diagnostic targets.
@ast
Complex humoral immune respons ...... ntigens as diagnostic targets.
@en
P2093
P2860
P356
P1476
Complex humoral immune respons ...... ntigens as diagnostic targets.
@en
P2093
Andrea Zippel
Andreas Keller
Christina Backes
Dominik Monz
Eckart Meese
Hans-Peter Lenhof
Jens Mayer
Nicole Comtesse
Nicole Ludwig
Sascha Walle
P2860
P304
P356
10.1073/PNAS.0500404102
P407
P577
2005-06-27T00:00:00Z